NASDAQ:HRTX
Heron Therapeutics Stock News
$2.87
+0.0300 (+1.06%)
At Close: May 07, 2024
Zoetis (ZTS) Misses Q2 Earnings Estimates
12:35pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Zoetis (ZTS) delivered earnings and revenue surprises of -1.64% and 1.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics to cut about one-third of its workforce as part of cost-cutting plan
08:41am, Thursday, 30'th Jun 2022
Heron Therapeutics Inc. HRTX, +3.26% said Thursday it will lay off about one-third of its workforce as part of a restructuring expected to save $43 million a year. The biotechnology company's stock wa
Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference
04:05pm, Thursday, 26'th May 2022
SAN DIEGO , May 26, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
10:45pm, Monday, 09'th May 2022 Zacks Investment Research
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -40% and 6.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
08:18pm, Monday, 09'th May 2022
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -40% and 6.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q1 2022 Results - Earnings Call Transcript
07:56pm, Monday, 09'th May 2022
Heron Therapeutics, Inc. (NASDAQ:HRTX ) Q1 2022 Results Conference Call May 9, 2022 4:30 PM ET Company Participants David Szekeres - EVP and COO Barry Quart - Chairman and CEO John Poyhonen - Presiden
Heron Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference
04:05pm, Tuesday, 05'th Apr 2022
SAN DIEGO , April 5, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatm
Heron Therapeutics: Cash Is A Problem Again
12:54pm, Thursday, 31'st Mar 2022
Heron has lost 60% of its value in less than a year, despite the company making some progress.
3 Growth Stocks To Sell Cash-Secured Puts On Now
05:05am, Tuesday, 29'th Mar 2022 Seeking Alpha
Small and mid-cap growth stocks are where the discounts are right now. Click to see 3 stocks that I think are currently cheap and offer fat put premiums.
Heron Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation
09:13pm, Friday, 04'th Mar 2022 Seeking Alpha
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
09:00pm, Friday, 04'th Mar 2022 The Motley Fool
Here's why our roundtable loves Legend Biotech, Heron Therapeutics, and Pieris Pharmaceuticals.
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
09:00pm, Friday, 04'th Mar 2022 The Motley Fool
Here''s why our roundtable loves Legend Biotech, Heron Therapeutics, and Pieris Pharmaceuticals.
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
04:00pm, Friday, 04'th Mar 2022
Here's why our roundtable loves Legend Biotech, Heron Therapeutics, and Pieris Pharmaceuticals.
Heron Therapeutics: Changing Strategy After Disappointing Earnings
01:46am, Thursday, 03'rd Mar 2022 Seeking Alpha
Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference | MarketScreener
09:06pm, Wednesday, 02'nd Mar 2022 MarketScreener
SAN DIEGO, March 2, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to… | March 2, 2022
